Skip to main content
. 2021 Apr 7;22(3):395–405. doi: 10.1007/s40257-021-00602-x
Download video file (85.2MB, mp4)

Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials (MP4 87244 kb)